A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19

Summary

This is an open-label uncontrolled study in which all participants will receive two doses of the inactivated adsorbed vaccine against COVID-19, and will be followed up for safety and immunogenicity analysis for 24 months.

Timeline

Start

2021-02-19

Primary completion

2021-09

Completion

2023-06

Drugs

Indications